arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2005.06201physics.bio-phq-bio.BM

用于疫苗开发的SARS-CoV-2辐射诱导灭活的Monte Carlo模拟

Monte Carlo simulation of SARS-CoV-2 radiation-induced inactivation for vaccine development

Ziad Francis, Sebastien Incerti, Sara A. Zein, Nathanael Lampe, Carlos A. Guzman, Marco Durante

AI总结:

本研究使用Monte Carlo工具包Geant4-DNA模拟电离辐射对SARS-CoV-2的灭活,发现加速带电粒子相比gamma射线能减少包膜蛋白损伤,为疫苗开发提供新方法。

摘要:

使用灭活病毒进行免疫是目前正在测试的SARS-CoV-2疫苗开发策略之一。灭活病毒的方法之一是暴露于高剂量的电离辐射以破坏其核酸。尽管gamma射线能有效诱导RNA损伤,但包膜蛋白在此过程中也会受到严重破坏。这反过来可能改变其抗原特性,影响其诱导能够提供有效保护的适应性免疫反应的能力。在此,我们使用Monte Carlo工具包Geant4-DNA模拟了稀疏和密集电离辐射对SARS-CoV-2的影响。利用真实的3D靶病毒模型,我们计算了spike和membrane蛋白以及病毒RNA中预期的损伤数量。我们表明,gamma射线会对spike蛋白造成重大损伤,但在相同的RNA损伤水平下,密集电离的带电粒子引起的membrane损伤较小,因为单个离子穿过核包膜就足以使病毒灭活。我们提出,加速带电粒子能产生对包膜蛋白结构损伤较小的灭活病毒,从而为开发针对SARS-CoV-2和其他包膜病毒的疫苗提供了一种新的有效工具。

英文摘要:

Immunization with an inactivated virus is one of the strategies currently being tested towards developing a SARS-CoV-2 vaccine. One of the methods used to inactivate viruses is exposure to high doses of ionizing radiation to damage their nucleic acids. Although gamma-rays effectively induce lesions in the RNA, envelope proteins are also highly damaged in the process. This in turn may alter their antigenic properties, affecting their capacity to induce an adaptive immune response able to confer effective protection. Here, we modelled the impact of sparsely and densely ionizing radiation on SARS-CoV-2 using the Monte Carlo toolkit Geant4-DNA. With a realistic 3D target virus model, we calculated the expected number of lesions in the spike and membrane proteins, as well as in the viral RNA. We show that gamma-rays produce significant spike protein damage, but densely ionizing charged particles induce less membrane damage for the same level of RNA lesions, because a single ion traversal through the nuclear envelope is sufficient to inactivate the virus. We propose that accelerated charged particles produce inactivated viruses with little structural damage to envelope proteins, thereby representing a new and effective tool for developing vaccines against SARS-CoV-2 and other enveloped viruses.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑